Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63...

18
Preliminary Program Falk Symposium 180 IBD 2011: Progress and Future for Lifelong Management November 11 – 12, 2011 ANA InterContinental Tokyo Tokyo, Japan Application for CME credits submitted

Transcript of Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63...

Page 1: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

Preliminary Program

Falk Symposium 180

IBD 2011: Progress and Futurefor Lifelong Management

November 11 – 12, 2011ANA InterContinental TokyoTokyo, Japan

Application for CME credits submitted

Page 2: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

3

Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

Scientific Program . . . . . . . . . . . . . . . . . . . . . . . . . 6

Posters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10

List of Speakers . . . . . . . . . . . . . . . . . . . . . . . . . . . 11

Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

CME credits for the Falk Symposium 180 have been applied for at the European Union of Medical Specialists (UEMS) – European Board of Gastroenterology (EBG). The number of credits awarded will be printed in the final program.

Page 3: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

4

Preface

Dear friends and colleagues,

We are proud and glad to welcome all of you to FALK Symposium 180, which is held for the first time in Japan. Inflammatory bowel disease (IBD) is a chronic intestinal disorder of unknown etiology. The theme of this meeting is ”IBD 2011: Progress and Future for Lifelong Management”. In recent years, IBD therapeutics have been dramatically changed by the appearance of the biologics. It also raises us a new mission to maintain long-term remission resulting in avoiding the disability and to manage adverse effects carefully.

We are also glad that basic researchers and clinical experts of IBD in Asian countries will join us. IBD has their highest prevalence in Western industrialized countries of Europe and North America. However, as you know, the accumulative numbers of IBD patients have been increasing in Japan and other Asian countries. Therefore, we will also focus on exchange between Western countries and Asian IBD experts in this meeting.

We hope this meeting will contribute to further development of IBD management and stimulate Asian IBD experts. We look forward to see you in Tokyo.

Toshifumi Hibi Markus F. Neurath Mamoru Watanabe

Page 4: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

Falk Symposium 180

IBD 2011: Progress and Futurefor Lifelong Management

ANA InterContinental TokyoTokyo, Japan

5

Registration:Thursday, November 10, 201116.00 – 21.00 hat the congress offi ce

Scientifi c Organization:T. Hibi, Tokyo (Japan)M. F. Neurath, Erlangen (Germany)M. Watanabe, Tokyo (Japan)

Congress Venue:ANA InterContinental Tokyo1-12-33 Akasaka, Minato-kuTokyo 107-0052Japan

Information:Prof. Dr. Toshifumi HibiKeio UniversitySchool of Medicine35, Shinano-machiShinjuku-ku Tokyo 160-8582JapanTelephone: +81(0)3/33 53 12 11Telefax: +81(0)3/53 63 36 63E-mail: [email protected]

Offi cial Language:English and Japanese(Simultaneous translation)

Posters:For details see page 10

Publication date of fi nal program: November 2011

The fi nal program will be available on the homepage www.falkfoundation.org one week before.

Page 5: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

6

Friday, November 11, 2011

8.15 Opening remarks T. Hibi, Tokyo

Keynote Lecture I

Chair: D. K. Podolsky, Dallas

8.20 Difference between Western countries and Asia on T. Hibi, genetics, diagnosis and therapeutic management of IBD Tokyo

Session I Insight into genetics, immunology and regenerative science for understanding the etiology of IBD

Chair: T. Chiba, Kyoto; L. Mayer, New York

9.00 Translating the new IBD genetics into therapy S. Schreiber, Kiel

9.30 Role of innate immunity on IBD pathogenesis R. J. Xavier, Boston

10.00 Role of adoptive immunity on IBD pathogenesis M. F. Neurath, Erlangen

10.30 Coffee break with poster session

Session II Biomarkers in IBD

Chair: S. Miura, Saitama; S. R. Targan, Los Angeles

10.50 Intestinal bacteria & pathogenesis A. Darfeuille-Michaud, Clermont-Ferrand

11.20 Biomarkers, impacts on pathogenesis & diagnosis I. Dotan, Tel Aviv

State-of-the-Art Lecture I

Chair: T. Chiba, Kyoto

11.50 Differential impact of the microbiota on colitis & colitis R. B. Sartor, associated colorectal cancer Chapel Hill

12.30 Lunch break with poster session

Page 6: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

7

Friday, November 11, 2011

State-of-the-Art Lecture II

Chair: R. B. Sartor, Chapel Hill

13.50 Regenerative science in IBD M. Watanabe, Tokyo

Session III New technology for diagnosis of IBD

Chair: P.-J. Hu, Guangzhou; H. Tajiri, Tokyo

14.30 Current topics of MRI for diagnosis of IBD J. Panés, Barcelona

15.00 Current topics of con-focal endoscopy for diagnosis R. Kiesslich, of IBD Mainz

15.30 Current topics of endoscopy for diagnosis of IBD and S. Kudo, cancer surveillance Yokohama

16.00 Coffee break with poster session

Session IV Surgery and post-operative management

Chair: W. Bemelman, Amsterdam; I. Sasaki, Sendai

16.20 Current problem and topics of IBD surgery A. Sugita, Yokohama

State-of-the-Art-Lecture III

Chair: W. Bemelman, Amsterdam; I. Sasaki, Sendai

16.50 Post-operative management for IBD patients S. B. Hanauer, Chicago

17.30 End of afternoon session

Page 7: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

8

Saturday, November 12, 2011

Session V Current therapeutic strategy depend on the treatment guidelines in USA, EU, Asia and Japan

Chair: E. V. Loftus, Rochester; M. Watanabe, Tokyo

8.30 Introduction M. Watanabe, Tokyo

8.40 USA S. Plevy, Chapel Hill

9.00 EU G. D’Haens, Amsterdam

9.20 Asia (China) J.-M. Qian, Beijing

9.40 Japan F. Ueno, Kanagawa

10.00 Discussion and perspectives Speakers and Moderators

10.30 Coffee break with poster session

Session VI Biologics and immuno-modulators: Benefit and risk for lifelong management

Chair: H. Ogata, Tokyo; E. F. Stange, Stuttgart

10.50 Benefit and risk of immuno-modulators for lifelong T. Matsumoto, management Hyogo

11.20 Strategy for treatment after anti-TNF failure D. W. Hommes, Leiden

State-of-the-Art Lecture IV

Chair: H. Goto, Nagoya

11.50 Side effect – Benefit and risk for lifelong management? P. Rutgeerts, Leuven

12.30 Lunch break with poster session

Page 8: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

9

Saturday, November 12, 2011

13.40 Poster Session

14.30 Presentation of Poster Prizes M. F. Neurath, Erlangen

Session VII Special management issues of IBD

Chair: W. Kruis, Cologne; T. Matsui, Fukuoka

14.40 Special management for pregnant IBD patients M. T. Abreu, Miami

15.10 Special management for pediatric IBD patients M. C. Dubinsky, Los Angeles

15.40 Nutritional management for IBD patients Y. Fujiyama, Shiga

16.10 Cancer surveillance for lifelong management T. Watanabe, Tokyo

16.40 Coffee break with poster session

Keynote lecture II

Chair: T. Hibi, Tokyo

16.50 Novel therapeutics for IBD W. J. Sandborn, La Jolla

17.30 Concluding remarks M. Watanabe, Tokyo

Page 9: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

10

Poster SessionPosters will be exhibited on November 11–12, 2011, at the ANA InterContinental Tokyo.The authors will be in attendance during coffee and lunch breaks on both days.

Call for postersPlease submit your poster abstract before July 31, 2011. Only one-page abstracts not exceeding 250 words, written in English and saved in Microsoft Word format will be accepted.

Abstracts must be submitted via our Internet Abstract Submission System (http://www.falkfoundation.com/poster) where further information regarding the submission format and the submission process is available.

The abstracts will be selected by the scientific organizers, preference being given to those thematically related to one of the sessions of the program.

The accepted abstracts will be printed and distributed to the participants of the congress together with the documents of the meeting.

The authors will receive notification about acceptance and further instructions in August 2011.

Contact address for further information on the poster session:

Falk Foundation e.V. P.O. Box 6529 79041 Freiburg/Germany Telephone: +49 (0) 761 / 15 14 - 0 Telefax: +49 (0) 761 / 15 14 - 359 Web address for submitting poster abstracts: http://www.falkfoundation.com/poster

For the first author of an accepted poster, expenses for accommodation (November 10 – 13, 2011) and fees for the scientific program and evening activities will be covered during the Falk Symposium 180. Travel expenses are not covered.

Poster prizesThree prizes will be awarded for the best presentations.Prize winners will be presented with a prize certificate and 1.500,-, 1.000,- and

500,- respectively. Travel expenses will be covered additionally for the first author of prize winning posters.

Page 10: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

11

List of Speakers, Moderators and Scientific Organizers

Maria T. Abreu, M.D.Professor of MedicineUniversity of MiamiMiller School of MedicineDivision of GastroenterologyP. O. Box 016960Miami FL [email protected]

Dr. Willem BemelmanUniversiteit van AmsterdamTytgat Institutefor Liver & Intestinal ResearchDepartment of SurgeryMeibergdreef 91105 AZ [email protected]

Prof. Dr. Tsutomu ChibaKyoto UniversityGraduate School of MedicineDepartment of Gastroenterology& Hepatology54, Kawahara-choShogoin Sakyo, Kyoto [email protected]

Dr. Arlette Darfeuille-MichaudUniversité d‘AuvergneCBRVLaboratoire de BactériologiePathogénie Bactérienne Intest.26 Place H. Dunant63000 [email protected]

Prof. Dr. Geert D‘HaensAcademic Medical CenterAfdeling MDL C2-331Meibergdreef 91105 AZ [email protected]

Dr. Iris DotanTel Aviv Medical CenterIchilov HospitalDepartment of Gastroenterology6, Weizman Street64239 Tel [email protected]

Marla C. Dubinsky, M.D.Assoc. Professor of PediatricsUniv. of California, Los AngelesCedars-Sinai Medical CenterDirector, Pediatric IBD Center8635 West Third StreetLos Angeles CA [email protected]

Prof. Dr. Yoshihide FujiyamaShiga University of MedicalScienceDivision of GastroenterologySeta Tsukinowa-choOtsu Shiga 520 [email protected]

Prof. Dr. Hidemi GotoNagoya University GraduateSchool of MedicineDepartment of Gastroenterology65, Tsuruma-Cho, Showa-kuNagoya [email protected]

Stephen B. Hanauer, M.D.Professor of MedicineUniversity of ChicagoDepartment of MedicineGastroenterology Section5841 S. Maryland Ave.Chicago IL [email protected]

Page 11: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

12

Prof. Dr. Toshifumi HibiKeio UniversitySchool of MedicineDepartment of Internal Medicine35, Shinano-machiShinjuku-ku Tokyo [email protected]

Prof. Dr. Daan W. HommesAcademisch Ziekenhuis LeidenAfd. MDL C4 PAlbinusdreef 22333 ZA [email protected]

Prof. Dr. Pin-Jin HuSun-Yat-Sen Universityof Medical SciencesGI Department58 Second Zhong Shan Road510080 GuangzhouP. R. [email protected]

Prof. Dr. Ralf KiesslichInnere Medizin IUniversitätsmedizin derJohannes Gutenberg-UniversitätLangenbeckstr. 155131 [email protected]

Prof. Dr. Wolfgang KruisInnere MedizinEvang. Krankenhaus KalkBuchforststr. 251103 Kö[email protected]

Prof. Dr. Shinei KudoShowa UniversityNorthern Yokohama HospitalDigestive Disease Center35-1 Chigasaki-chuo, Tsuzuki-kuYokohama [email protected]

Edward V. Loftus, M.D.Professor of MedicineMayo ClinicDivision of Gastroenterology200 First Street SWRochester MN [email protected]

Prof. Dr. Toshiyuki MatsuiFukuoka UniversityChikushi HospitalDepartment of Gastroenterology1-1-1 Zokumyoin, ChikushinoFukuoka [email protected]

Prof. Dr. Takayuki MatsumotoHyogo College of MedicineDivision of LowerGastrointestinal Disease1-1, Mukogawacho, NisinomiyaHyogo [email protected]

Lloyd Mayer, M.D.Professor of MedicineMount Sinai School of MedicineClinical Immunology, Rm 11-201425 Madison Ave.New York NY [email protected]

Prof. Dr. Soichiro MiuraNational DefenseMedical CollegeDepartment of Internal Medicine3-2 Namiki, TokorozawaSaitama [email protected]

Page 12: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

13

Prof. Dr. Markus F. NeurathMedizinische Klinik 1Universitätsklinikum ErlangenUlmenweg 1891054 [email protected]

Prof. Dr. Haruhiko OgataKeio UniversitySchool of MedicineDepartment of Internal MedicineDiagnostic/Therapeutic Endoscopy35 ShinanomachiShinjuku-ku Tokyo [email protected]

Dr. Julián PanésHospital Clinico y ProvincialUniversidad de BarcelonaInflammatory Bowel Disease Unitc/ Villarroel no. 17008036 [email protected]

Scott Plevy, M.D.University of North CarolinaGastroenterology & Hepatology7300 MBRB, CB# 7032130 Mason Farm RoadChapel Hill NC [email protected]

Daniel K. Podolsky, M.D.Professor of MedicineUniversity of TexasSouthwestern Medical Center5323 Harry Hines Blvd.Dallas TX [email protected]

Prof. Dr. Jia-Ming QianBeijing UnionMedical College HospitalDepartment of Gastroenterology1 Shuaifu Garden, Dongcheng100730 BeijingP. R. [email protected]

Prof. Dr. Paul RutgeertsUniversity ZiekenhuisGasthuisbergGastro-entérologieHerestraat 493000 [email protected]

William J. Sandborn, M.D.Professor of MedicineUCSD School of MedicineDivision of GastroenterologyBuilding UC 303, Room 2209500 Gilman DriveLa Jolla CA [email protected]

R. Balfour Sartor, M.D.Professor of MedicineUniversity of North CarolinaSchool of MedicineGastroenterology & Hepatology111 Mason Farm RoadChapel Hill NC [email protected]

Prof. Dr. Iwao SasakiTohoku UniversityGraduate School of MedicineDepartment of Surgery1-1 Seiryo-machi, Aoba-kuSendai [email protected]

Page 13: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

14

Prof. Dr. Stefan SchreiberInnere Medizin IUniversitätsklinikumSchleswig-Holstein, Campus KielArnold-Heller-Straße 3 (Haus 6)24105 [email protected]

Prof. Dr. Eduard F. StangeInnere Medizin IRobert-Bosch-KrankenhausAuerbachstr. 11070376 [email protected]

Prof. Dr. Akira SugitaYokohama Municipal Citizens HospitalDepartment of Surgery56 Okazawa-cho, Hodogaya-kuYokohama [email protected]

Prof. Dr. Hisao TajiriThe Jikei UniversitySchool of MedicineDepartment of Gastroenterology& Hepatology3-25-8, Nishi-Shimbashi Minato-kuTokyo [email protected]

Stephen R. Targan, M.D.Professor of MedicineCedars-Sinai Medical CenterDavis Research Center#D-4063 (1865)8700 Beverly Blvd.Los Angeles CA [email protected]

Dr. Fumiaki UenoOfuna Chuo HospitalDepartment of Medicine6-2-24 Ofuna, Kamakura-shiKanagawa [email protected]

Prof. Dr. Mamoru WatanabeTokyo Medical & Dental UniversitySchool of MedicineDepartment of Gastroenterology1-5-45, Yushima, Bunkyo-kuTokyo [email protected]

Prof. Dr. Toshiaki WatanabeTeikyo UniversitySchool of MedicineDepartment of Surgery2-11-1, Kaga, Itabashi-KuTokyo [email protected]

Ramnik Joseph Xavier, M.D.Massachusetts General HospitalSchool of MedicineGI Unit55 Fruit StreetBoston MA [email protected]

Page 14: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

15

General InformationPrior to the opening of the congress in Tokyo

Falk Foundation e. V. Telephone: +49 (0) 761 / 15 14 - 0Congress Division Telefax: +49 (0) 761 / 15 14 - 359Leinenweberstr. 5 E-mail: [email protected]. Box 652979041 Freiburg/Br. (Germany)

Congress OfficeDuring the Falk Symposium 180

ANA InterContinental Tokyo Telephone: +49(0)171/7 84 61 151-12-33 Akasaka, Minato-ku Telefax: +81(0)3/35 05 11 55Tokyo 107-0052Japan

Opening Hours:Thursday, November 10, 2011 16.00 – 21.00 hFriday, November 11, 2011 7.15 – 17.30 hSaturday, November 12, 2011 8.00 – 17.30 h

Congress FeesScientific program of the Falk Symposium 180 200,-Students and residents 100,-

* * * OR * * *

Day ticket 120,-Students and residents 60,-

The congress fees include:- Welcome Evening on November 10, 2011- Refreshments during coffee breaks- Lunch on November 11 and 12, 2011- A copy of the abstract volume

Page 15: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

16

RegistrationCongress registrations must reach the Falk Foundation e.V. by September 15, 2011 at the latest. Congress fees may be paid by cheque payable to the Falk Foundation e.V. or by bank transfer to Volksbank Freiburg e.G., Germany, Bank No. 68090000, Account No. 1452010, IBAN DE33 6809 0000 0001 4520 10, BIC Genode 61 FR1. Please mark bank transfers with ”Falk Symposium 180”.

To ensure correct registration, participants are asked to send in their registration and the fee remittance together.

After receipt of registration form, each participant will be provided with confirmation of his registration. On presentation of this confirmation at the Congress Office in Tokyo participants will receive the congress folder containing name badges, admission tickets and the abstract volume.In the event of registration cancellations, a handling fee of EUR 20,- will be deducted from the refund. All participants will receive a written confirmation of attendance at the end of the meeting.

Admission to Scientific EventsFor admission to scientific events your name badge should be clearly visible.

Hotel AccommodationHotel reservations can be made online:www.booking.com/hotels

Congress ReportThe official congress report of the Falk Symposium 180 “IBD 2011: Progress and Future for Lifelong Management” will be published in English in the first half of 2012 by Karger Publishers, Basel, Switzerland. Orders for this book at a reduced subscripti-on price of 35,- can be placed at the Congress Office during the congress in Tokyo.

AirportTokyo International Airport (Haneda)Narita International Airport

Page 16: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous
Page 17: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous
Page 18: Preliminary Program - Dr. Falk Pharma...Telephone: +81(0)3/33 53 12 11 Telefax: +81(0)3/53 63 36 63 E-mail: thibi@sc.itc.keio.ac.jp Offi cial Language: English and Japanese (Simultaneous

General Information:

FALK FOUNDATION e.V.Leinenweberstr. 579108 FreiburgGermany

Congress DivisionTelephone: +49(0)761/1514-0Telefax: +49(0)761/1514-359E-mail: [email protected] VP

180

1-2

/201

1/6.

00

0 St

ü

Ajinomoto Pharmaceuticals Co., Ltd.2-1-1, Irifune, Chuo-kuTokyo 104-0042Japan

Co-sponsor: